Understanding genetic risk spots for glaucoma
Foundational Biology of Glaucoma GWAS Loci
['FUNDING_R01'] · UNIVERSITY OF IOWA · NIH-11262890
This project looks at specific genetic changes linked to glaucoma to find how they raise risk for people with or at risk for primary open-angle glaucoma.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF IOWA (nih funded) |
| Locations | 1 site (IOWA CITY, UNITED STATES) |
| Trial ID | NIH-11262890 on ClinicalTrials.gov |
What this research studies
As someone with or worried about glaucoma, this project digs into the DNA regions that genetic studies have linked to primary open-angle glaucoma. Researchers will map the exact genetic variants and candidate genes within those GWAS loci and then test how those changes affect eye cells using lab experiments and human tissue when available. The team will combine large-scale genetic data with functional lab work to pinpoint which variants are likely causal and to understand the biological processes they alter. That information is meant to reveal new pathways that could become targets for treatments that protect vision beyond lowering eye pressure.
Who could benefit from this research
Good fit: Ideal candidates for related human studies would include people with primary open-angle glaucoma, those with a strong family history of glaucoma, or individuals who have had glaucoma genetic testing.
Not a fit: Patients needing immediate vision-saving treatment or those whose glaucoma is already well controlled with existing therapies may not see direct short-term benefit from this foundational genetics research.
Why it matters
Potential benefit: If successful, this work could identify new biological targets that lead to treatments protecting retinal ganglion cells beyond current pressure-lowering therapies.
How similar studies have performed: Large GWAS have repeatedly found many glaucoma risk regions, but translating those signals into specific causal genes and mechanisms is still a new and emerging area with only initial successes.
Where this research is happening
IOWA CITY, UNITED STATES
- UNIVERSITY OF IOWA — IOWA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ANDERSON, MICHAEL G — UNIVERSITY OF IOWA
- Study coordinator: ANDERSON, MICHAEL G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer Disease 1 Protein, Alzheimer Disease Protease Nexin-II, Alzheimer disease dementia, Alzheimer syndrome